Iomai to be bought by austrian firm intercell ag

Iomai Corp. has agreed to sell itself to an Austrian vaccine maker for a cash-and-stock combination worth up to $189 million. Intercell AG, based in Vienna, Austria, plans to buy the Gaithersburg company for $119 million in cash, which will pay for 59 ...Iomai shares surge on premium buyout offer ForbesIntercell cuts Q1 net loss ReutersTheStreet.com - Baltimore Sun - TechJournal South - FierceBiotech